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The escape mechanism of parasites from inﬂammatory processes has been thought to be 
one of the most important tools for their survival in infected tissues.  On the other hand, 
inducible cyclooxygenase-2 (cox-2) has been shown to play a major role in the process of 
inﬂammation.  We investigated the effect of excretory/secretory (ES) products from the 
plerocercoids of Spirometra erinaceieuropaei on cox-2 gene expression in a murine mac-
rophage cell line (RAW 264.7).  Preincubation of the macrophages with the ES products 
inhibited LPS-induced cox-2 mRNA expression by 75% as well as its protein production. 
Dibutyryl cAMP enhances LPS-induced cox-2 mRNA expression.  The ES products 
also inhibited this enhanced expression by 46%.  Inhibition of p38 mitogen-activated 
protein kinase (MAPK) with SB203580 or that of extracellular signal-regulated protein 
kinase with PD98059 reduced LPS-induced cox-2 mRNA expression by 75% or 52%, 
respectively, along with its protein production.  This evidence suggests that both MAPK 
pathways are crucial for full induction of cox-2 gene expression.  One experiment using a 
transcriptional inhibitor, actinomycin-D, showed that the ES products destabilized LPS-
induced cox-2 mRNA in RAW 264.7 macrophages.  These results show that ES prod-
ucts from the plerocercoids of Spirometra erinaceieuropaei suppress LPS-induced cox-2 
mRNA expression in murine RAW 264.7 macrophages, and may attenuate inﬂammation 
around the plerocercoids of S. erinaceieuropaei. 
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Cyclooxygenase (cox) catalyzes the synthesis of 
prostaglandins (PGs) from arachidonic acid.  Two 
isozymes, cox-1 and cox-2, have been identified, 
and they are encoded by separate genes.  The 
cox-1 isozyme is constitutively present in most tis-
sues and seems to catalyze the synthesis of PGs 
for normal physiological functions (O’Neill and 
Ford-Hutchinson, 1993).  In contrast, cox-2 is not 
or is scarcely detectable in most tissues under bas-
al conditions, but is dramatically induced by bac-
terial lipopolysaccharide (LPS), cytokines, growth 
factors or carcinogens (Kujubu et al., 1991). 
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 The cox-2 isozyme is responsible for high 
levels of PG production, and secreted PGs are 
involved in various physiological events including 
progression of inflammation, immunomodula-
tion, and transmission of pain (Vane and Boot-
ing, 1998; Kim et al., 2004).  The central role of 
PGs in inﬂammation was ﬁrmly established after 
the discovery that the anti-inflammatory action 
of nonsteroidal anti-inﬂammatory drugs, such as 
acetylsalicylic acid, was mediated by the inhibi-
tion of cox.  It has been widely accepted that mac-
rophages play an important role in the regulation 
of inflammation and immune response.  In in-
ﬂammatory reactions, macrophages are the main 
producers of large quantities of PGE2 (Giroux and 
Descoteaux, 2000). 
 Parasite survival may depend on the ability 
of the parasite to modulate host immune response 
by the release of immunomodulatory molecules 
that protect the organism (Maizels et al., 2001; 
Harnett et al., 2004).  When larval plerocercoids 
of S. erinaceieuropaei are taken orally in many 
mammals including humans and rodents, these 
plerocercoids invade the peritoneal cavity from 
the intestine, and can survive in the tissues of 
hosts.  In humans, infection with larval plero-
cercoids causes “sparganosis” in various tissues 
(Kudesia et al., 1998).  Experimentally infected 
plerocercoids do not induce the strong inﬂamma-
tory responses around the parasites and they can 
survive for long periods in the tissues of mice; 
hence, we hypothesized that larval plerocercoids 
of S. erinaceieuropaei secrete an immunosuppres-
sive factor(s).  We previously showed that excre-
tory/secretory (ES) products from plerocercoids 
suppress LPS-induced expressions of chemokines 
KC and JE, the murine homologues of neutro-
phil chemoattractant growth related oncogene α 
(CXCL1/GRO-α) and monocyte chemoattractant 
protein-1 (CCL2/MCP-1), respectively (Fukumoto 
et al., 1997), tumor necrosis factor (TNF)-α (Mi-
ura et al., 2001; Dirgahayu et al., 2002), and IL-1β 
(Dirgahayu et al., 2004) in murine macrophages. 
We also found that these suppressions are caused 
by the reduction of phosphorylation of mitogen-
activated protein kinase (MAPK), particularly 
extracellular signal-regulated kinase 1/2 (ERK1/2) 
and p38 MAPK (Dirgahayu et al., 2002; Dirga-
hayu et al., 2004).
 Studies using MAPK inhibitors, SB203580 
and PD98059 revealed that MAPK is involved in 
LPS-induced cox-2 transcription in RAW 264.7 
macrophages (Chanmugam et al., 1995; Hwang 
et al., 1997).  SB203580 inhibits the p38 MAPK 
pathway (Ajizian et al., 1999), and inhibits the 
promoter activities of cox-2 (Ho et al., 2004), 
while PD98059 is a specific inhibitor for the 
ERK1/2 pathway (Alessi et al., 1995).  In addition 
to the transcriptional effects of MAPK, AgC10, 
a mucin from Trypanosoma cruzi destabilized 
cox-2 mRNA by inhibiting the activation of p38 
MAPK (Alcaide and Fresno, 2004).
 Besides MAPKs, the importance of NF-κB 
for the induction of cox-2 in LPS-activated mono-
cyte-macrophage lineage has been emphasized (D’
Acquisto et al., 1998).  However, we found that ES 
products do not affect the LPS-induced nuclear 
translocation of NF-κB (Dirgahayu et al., 2002).   
 Since ES products have the ability to sup-
press the phosphorylation of ERK1/2 and p38 
MAPK in LPS-activated macrophages, we hy-
pothesized that ES products could suppress LPS-
induced cox-2 gene expression in macrophages. 
We have shown in this paper that ES products 
suppress LPS-induced cox-2 mRNA expression 
and cox-2 protein in RAW 264.7 cells, and ES 
products destabilize cox-2 mRNA.  This is the 
ﬁrst report demonstrating that ES products from 
the parasitic helminth reduce cox-2 mRNA and 
cox-2 protein in macrophages. 
Materials and Methods
Plerocercoids of Spirometra erinaceieuro-
paei and their ES products 
Plerocercoids of Spirometra erinaceieuropaei 
were collected from two species of snakes (Elaphe 
quadrivirgata and Rhabdophis tigrinus) in Ehime 
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Prefecture, Japan and stored for 6 to 10 months 
in the subcutaneous tissues of golden hamsters, 
which were housed and maintained according to 
the guidelines for proper treatment of animals at 
the Research Center for Bioscience and Technol-
ogy, Tottori University, Japan.  ES products were 
obtained as described previously (Miura et al., 
2001).  To obtain ES products, 25 plerocercoids 
aseptically removed from hamsters were incubat-
ed for 24 h in serum-free 25 mL Dulbecco’s mod-
iﬁed Eagle’s medium (DMEM) in a 10 cm dish, 
and the incubation medium was dialyzed against 
distilled water and lyophilized.  The protein con-
centration of this sample dissolved in DMEM 
was assayed using a protein assay kit (Bio-Rad, 
Melville, NY) and adjusted to 50 µg/mL.  The av-
erage amount of total protein secreted from each 
plerocercoid for 24 h was approximately 30 µg in 
the present experiment. 
 
Culture of macrophages
A murine macrophage cell line RAW 264.7 
(RCB0535) was purchased from RIKEN Cell 
Bank (Wako, Japan).  The cells were cultured in 
DMEM supplemented with 5% heat-inactivated 
fetal bovine serum (FBS) (Invitrogen, Carlsbad, 
CA) containing 100 U/mL penicillin G (Banyu 
Pharmaceutical, Tokyo, Japan) and 100 µg/mL 
streptomycin (Meiji Seika, Tokyo, Japan), plated 
in tissue culture dishes (Greiner Bio-One, Tokyo, 
Japan) and ﬁnally incubated at 37˚C in an atmo-
sphere of 5% CO2 in a humidiﬁed incubator.  In 
the present study, 5 × 106 cells were preincubated 
in a 10 cm culture dish for 3 h or 6 h in the pres-
ence or absence of ES products (5 µg/mL).  The 
cells were washed with PBS and stimulated with 
LPS (100 ng/mL) in DMEM supplemented with 
5% FBS.  After 3 h of incubation with LPS, large 
amounts of cox-2 mRNA were expressed in a 
time-course experiment.  Then, the cells were 
incubated with LPS for 3 h in the present experi-
ments.  A concentration of 5 µg/mL ES products 
was used, because this concentration had been 
effective in TNF-α gene expression (Miura et al., 
2001), and similar activation pathways such as 
NF-κB and MAPK are involved in LPS-induced 
cox-2 and TNF-α gene expressions.
Reverse transcription-PCR analysis
Total RNA was prepared using an ISOGEN Kit 
(Nippon Gene, Tokyo, Japan) according to the 
manufacturer’s protocol.  Total RNA (1 µg) was 
reverse-transcribed, and PCR reactions were per-
formed on a Perkin Elmer DNA Thermal Cycler 
(Takara Bio, Kusatsu, Japan).  Primers used were 
as follows: cox-2: 517 bp, 5'-CTT CCT GAT CAA 
AAG AAG TGC TG-3' (sense) and 5'-ACT TGA 
GTT TGA AGT GGT AAC CGC-3' (antisense); 
and β -actin: 349 bp, 5'-TGG AAT CCT GTG 
GCA TCC ATG AA-3' (sense) and 5'-TAA AAC 
GCA GCT CAG TAA CAG TCC-3' (antisense). 
The PCR cycles consisted of denaturation at 94˚C 
for 30 s, annealing at 60˚C for 1 min and exten-
sion at 72˚C for 1 min.  The number of cycles used 
was 29 for semi-quantitative analysis of cox-2 
or 25 for β-actin.  A 15-µL aliquot of each PCR 
product was separated by electrophoresis on a 
1.5% agarose gel, stained with ethidium bromide 
and photographed.  For quantification, photo-
graphs showing PCR products were scanned and 
analyzed using the software Densitograph version 
4.0 (ATTO, Tokyo, Japan).  The amount of cox-2 
mRNA was normalized to that of β-actin.
 
Preparation of total RNA and Northern 
blot analysis 
Northern hybridization analysis was performed 
as previously described (Fukumoto et al., 1997). 
Brieﬂy, 10 µg of total RNA was separated on an 
1% agarose gel containing 2.2 M formaldehyde, 
and subsequently blotted onto a MagnaGraph 
Nylon transfer membrane (Micron Separation, 
Westboro, MA) and then cross-linked to the mem-
brane using an UV cross-linker (Funa-UV-Linker 
Fs 1500, Funakoshi, Tokyo, Japan).  After prehy-
bridization, the blots were hybridized with cDNA 
plasmid probes radiolabelled by [α-32P]dCTP 
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(MP Biomedicals, Irvine, CA) using a Takara 
BcaBEST Labelling Kit (Takara Bio), and then 
autoradiography was performed.  The murine-517 
bp of the cox-2 cDNA fragment was prepared by 
RT-PCR, followed by conﬁrmation with sequenc-
ing.  A plasmid encoding the glyceraldehyde-3-
phosphate dehydrogenase (gapdh) cDNA, used as 
a control, was kindly provided by Dr. David Stern 
(Columbia University).  Relative cox-2 mRNA 
expressions were analyzed using a Molecular Im-
ager, Model GS-535 (Bio-Rad) with reference to 
the expression of gapdh mRNA. 
Preparation of cell lysate and Western blot
After the treatment, cell lysates were prepared 
as previously described (Dirgahayu et al., 2002). 
Brieﬂy, the adherent cells were disrupted in cold 
lysis buffer (20 mM Tris, pH 7.5, 120 mM EDTA, 
10% glycerol, 1% Triton X-100, 1 mM sodium 
orthovanadate, 1 mM phenylmethylsulfonyl ﬂuo-
ride, 5 µg/mL aprotinin, 5 µg/mL pepstatin and 
5 µg/mL leupeptin), homogenized for 5 s using 
a microtube homogenizer, and then kept on ice 
for 30 min.  Insoluble material was removed by 
centrifugation at 4˚C, 12,500 rpm for 10 min and 
protein concentration in the clear supernatant was 
determined using a protein assay kit (Bio-Rad). 
The solubilized proteins (80 µg) were boiled in 
SDS-loading buffer, then separated on a 10% 
SDS-polyacrylamide gel with a running buffer 
containing 25 mM Tris, 192 mM glycine, pH 8.3, 
and 0.1% SDS.  After electrophoresis, the sepa-
rating gel was soaked in transfer buffer (25 mM 
Tris-HCl, 0.2 M glycine, 20% (v/v) methanol, pH 
8.5) for 15 min and electrophoretically transferred 
to Hybond-ECL nitrocellulose (Amersham Bio-
sciences, Piscataway, NJ) using a semidry blotting 
apparatus (Novablot, Amersham Biosciences), 
and then blocked overnight in Tris-buffered sa-
line/tween-20 (0.05%) supplemented with 3% 
non-fat milk.  The membranes were washed, 
incubated overnight with phospho-specific an-
tibody recognizing cox-2 (1:300) detected with 
anti-rabbit horseradish peroxidase-conjugated 
antibodies (1:3,000) and subsequently visualized 
by an enhanced chemiluminescence reagent (Am-
ersham Biosciences).  The gel was stained with 
Fig. 1.  Suppression of LPS-induced cox-2 mRNA expression in RAW 264.7 macrophages by ES products. RAW 
264.7 cells were left untreated or treated with ES products (5 µg/mL) for 3 h or 6 h, and the medium was replaced 
prior to stimulation with LPS (100 ng/mL) for 3 h. 
A: Total RNA was obtained from the cells, and the expression of cox-2 and gapdh mRNA was assessed by North-
ern blot analysis. 
B:  The cox-2 mRNA level was quantiﬁed and normalized to gapdh. The relative cox-2 mRNA levels are present-
ed as percentages of the LPS-induced control in the absence of ES products. 
C: The cox-2 protein in each cell lysate was analyzed by Western blot analysis. The same volume of each cell 
lysate was resolved by SDS-PAGE, and the gel was stained with Coomassie Brilliant Blue to show that total 
protein was equally loaded. One representative of 2 independent experiments is shown. 
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Fig. 2.  The suppressive effect of ES products on cox-2 
mRNA expression induced by dbcAMP and LPS. RAW 
264.7 cells were left untreated or preincubated with ES 
products for 6 h prior to medium change. The cells were 
then either left untreated or treated with dbcAMP (0.1 
mM) for 15 min and were then stimulated with LPS (100 
ng/mL) for 3 h. Total RNA was obtained from the cells 
and cox-2 and gapdh mRNA expression was assessed by 
Northern blot analysis (A).  The cox-2 mRNA level was 
quantified and was normalized to gapdh. The relative 
cox-2 mRNA levels are presented as percentages of the 
LPS-induced control in the absence of ES products and 
dbcAMP (100%) (B).  The ﬁgure is representative of 3 
independent experiments.
Coomassie Brilliant Blue to demonstrate that an 
equal amount of proteins was loaded in each lane. 
 
 
Results
Suppression of LPS-induced cox-2 mRNA 
expression by ES products
No appreciable band was observed in controls 
without LPS stimulation.  Firstly, the effect of ES 
products on cox-2 mRNA expression and pro-
tein production were investigated.  RAW 264.7 
cells were either left untreated or preincubated 
with ES products (5 µg/mL) for 3 h or 6 h.  The 
cells were stimulated with 100 ng/mL LPS for 3 
h.  Total RNA or total protein was subjected to 
Northern blot or Western blot, respectively.  The 
result shows that ES products strongly suppressed 
the levels of LPS-induced cox-2 mRNA (Figs. 1A 
and B) and cox-2 protein (Fig. 1C) to a similar de-
gree.  The level of constitutively expressed gapdh 
mRNA was unaltered by exposure to ES products. 
Since preincubation for 3 h or 6 h showed no sig-
niﬁcant differences on cox-2 mRNA expression or 
protein production, a 6 h pretreatment was used 
for the following experiments.
 
Suppressive effect of ES products on cox-2 
mRNA induced by dbcAMP and LPS 
The plerocercoids release PGE2 (Fukushima et 
al., 1993; Gao et al., 1998), which enhances the 
induction of LPS-induced cox-2 mRNA by an ad-
enyl cyclase/cAMP-dependent pathway (Hinz et 
al., 2000).  We tested the possibility of ES prod-
ucts on LPS-induced cox-2 mRNA expression in 
the presence of dibutyryl cAMP (dbcAMP).  As 
seen in Fig. 2, LPS-induced cox-2 mRNA expres-
sion (Lane 2) was further enhanced by treatment 
with dbcAMP 1.7 times (Lane 4).  Pretreatment of 
macrophages with ES products prior to stimula-
tion with LPS (Lane 3) or with LPS and dbcAMP 
(Lane 5) strongly suppressed cox-2 mRNA ex-
pression by 75% and 46%, respectively.  No ap-
preciable band was detected in the untreated con-
trol (Lane 1), nor in cells treated with dbcAMP 
or ES products without LPS-induction (data not 
shown). 
Involvement of MAPK in LPS-induced cox-2 
mRNA 
We examined the effects of MAPK inhibitors 
for the ERK1/2 pathway (PD98059) and for p38 
MAPK (SB203580) in LPS-induced cox-2 mRNA 
expression.  The macrophages were pretreated for 
1 h with SB203580 (10 µM), PD98059 (50 µM) 
or both, and these cells were then stimulated with 
LPS for 3 h.  The total RNA or protein was sub-
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jected to semi-quantitative RT-PCR or Western 
blot analysis, respectively.  SB203580 (Fig. 3A, 
Lane 2) and PD98059 (Lane 3) suppressed cox-2 
mRNA expression by 75% or 52%, respectively, 
and cox-2 protein production (Fig. 3C, Lanes 2, 
3, respectively).  The combination of both inhibi-
tors reduced the cox-2 mRNA (Fig. 3A, Lane 4) 
and cox-2 protein (Fig. 3C, Lane 4) to nearly null. 
Figure 3B shows the quantitative relations. 
 Next we examined the effect of ES products 
in combination with MAPK inhibitor(s) on cox-2 
mRNA expression by Northern blot analysis.  ES 
products or MAPK inhibitors reduced LPS-in-
duced cox-2 mRNA expression, and the combina-
tion with ES products and each MAPK inhibitor 
additively suppressed cox-2 mRNA expression 
(Fig. 4).
Destabilization of LPS-induced cox-2 mRNA 
by ES products
The level of cox-2 mRNA is regulated both tran-
scriptionally and post-transcriptionally (Wadleigh 
et al., 2000; Alcaide and Fresno, 2004).  There-
fore, we examined the effect of ES products 
on cox-2 mRNA stability in LPS-stimulated 
macrophages using a transcriptional inhibitor, 
Fig. 3.  Effect of MAPK inhibitors on LPS-induced cox-2 mRNA expression. RAW 264.7 cells were treated with 
PD98059 (50 µM), SB203580 (10 µM) or a combination of both for 1 h and were stimulated with LPS (100 ng/mL) 
for 3 h.  Total RNA and total protein were obtained from the cells and cox-2 and β-actin mRNA expressions were as-
sessed by semi-quantitative RT-PCR (A).  The cox-2 mRNA level was quantiﬁed and was normalized to β-actin.  The 
relative cox-2 mRNA levels are presented as percentages of the LPS-induced control in the absence of MAPK inhibi-
tor (B).  The cox-2 protein expression was assessed by Western blot analysis (C).  One representative of 2 independent 
experiments is shown. 
Fig. 4.  Additive suppression of LPS-induced cox-2 
mRNA expression by a combination of MAPK inhibitor 
and ES products.  RAW 264.7 cells were left untreated 
or preincubated with ES products (5 µg/mL) for 6 h prior 
to medium change.  The cells were then left untreated or 
treated either with PD98059, SB203580 or a combination 
of both for 1 h and were then stimulated with LPS (100 
ng/mL) for 3 h.  Total RNA was obtained from the cells 
and was subjected to Northern blot analysis (A).  The 
cox-2 mRNA level was quantiﬁed and was normalized to 
gapdh.  The relative cox-2 mRNA levels are presented as 
percentages of the LPS-induced control in the absence of 
ES products and MAPK inhibitor (100%) (B).  The ﬁgure 
is representative of the 3 independent experiments.
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Fig. 5.  Destabilization of LPS-induced cox-2 mRNA by ES products.  RAW 264.7 cells were left untreated or pre-
incubted with ES products (5 µg/mL) prior to medium change. The cells were then stimulated with LPS (100 ng/mL) 
for 3 h and treated with actinomycin D (10 µg/mL).  Total RNA was obtained at different time points (0, 15, 30, 60, 
90 and 120 min) after the addition of actinomycin D.  Total RNA was obtained from the cells and was subjected to 
Northern blot analysis.  The cox-2 mRNA expression was quantiﬁed and was normalized to gapdh.  One representa-
tive experiment of three is shown.  Act D, actinomycin D.
actinomycin-D.  As shown previously, the mac-
rophages were treated with ES products for 6 h, 
washed, and stimulated with LPS for 3 h.  Then 
the cells were further treated with actinomycin D 
(10 µg/mL) at varying intervals.  Total RNA was 
subjected to Northern blot hybridization to exam-
ine the remaining cox-2 mRNA.  As seen in Fig. 
5, cox-2 mRNA was degraded rapidly in macro-
phages treated with ES products, in comparison to 
cells without treatment of ES products.  The cox-2 
mRNA levels were normalized to gapdh mRNA 
levels.  The remaining cox-2 mRNA level at 90 
min was 43% in the absence of ES products or 
17% in the presence of ES products.  The level at 
120 min was 25% in the absence of ES products 
or 3% in the presence of ES products.  ES prod-
ucts reduced the stability of cox-2 mRNA.  
Discussion
Some parasites such as ﬁlarial nematodes secrete 
immunomodulatory molecules that protect the or-
ganism (Maizels et al., 2001; Harnett e al., 2004). 
The cox-2 isozyme has been known as one of the 
potent inflammatory factors of host inflamma-
tion through PGs (Vane and Booting, 1998; Kim 
et al., 2004).  We found that ES products from 
plerocercoids of S. erinaceieuropaei inhibit cox-2 
gene expression in LPS-activated macrophages. 
Although AgC10, a mucin from Trypanosoma 
cruzi, a protozoan parasite, is reported to desta-
bilize cox-2 mRNA (Alcaide and Fresno, 2004), 
this is the ﬁrst report that shows that the parasitic 
helminth suppresses cox-2 gene expression. 
 It is well known that PGE2 potentiates LPS-
induced cox-2 mRNA expression via an adenyryl 
cyclase/cAMP-dependent pathway (Hinz et al., 
2000).  As the plerocercoids released PGE2 in the 
supernatants of the in vitro culture (Fukushima 
et al., 1993; Gao et al., 1998), we also examined 
the effect of ES products on cox-2 mRNA expres-
sion stimulated by the cAMP-dependent pathway. 
Stimulation by dbcAMP, a cell-permeable cAMP 
analogue, could not induce cox-2 gene expres-
sion, but enhanced the induction of cox-2 mRNA 
by LPS, and the ES products suppressed the en-
hanced cox-2 mRNA expression.  These results 
suggest that ES products may inhibit the autocrine 
feed-forward loop of PGE2 in LPS-stimulated 
macrophages around the plerocercoids of S. eri-
naceieuropaei. 
 In agreement with other studies (Chanmugam 
et al., 1995; Hwang et al., 1997), we showed that 
ERK1/2 and p38 MAPK pathways are crucial for 
cox-2 gene expression and protein production in 
LPS-activated RAW 264.7 macrophages.  Of note, 
PD98059 (an inhibitor for the ERK1/2 pathway) 
and SB203580 (an inhibitor of the p38 MAPK 
pathway) additively suppressed gene expression 
(Figs. 3 and 4).  The ES products and both of 
MAPKs inhibitors also additively affected cox-2 
� ���
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gene expression (Fig. 4).  Recently, we reported 
that ES products suppress TNF-α mRNA expres-
sion by inhibiting ERK1/2 and p38 MAPK path-
ways in RAW 264.7 macrophages stimulated with 
LPS (Dirgahayu et al., 2002).  We also showed 
that ES products do not affect LPS-induced nu-
clear translocation of NF-κB by electrophoretic 
mobility shift assay (Dirgahayu et al., 2002), 
while the activation of NF-κB is important for the 
induction of cox-2 mRNA in the LPS-activated 
monocyte-macrophage lineage (D’Acquisto et al., 
1998).  Although the mechanism of suppression 
by ES products needs to be investigated further, 
these lines of data suggest the possibility that ES 
products suppress LPS-induced cox-2 gene ex-
pression by inhibiting ERK1/2 and p38 MAPK 
pathways.  
 Recently, p38 MAP kinase has been re-
ported to play a major role in mRNA stabilization 
through AU-rich elements in the 3'-untranslated 
regions (Winzen et al., 1999; Lasa et al., 2000 and 
2001). The 3'-untranslated region of cox-2 con-
tains 22 AUUUA motifs that are recognized to 
be important determinants of mRNA instability 
(Chen and Shyu, 1995; Zubiaga et al., 1995).  We 
observed that ES products reduce cox-2 mRNA 
stability (Fig. 5), and suppose that ES products 
destabilize cox-2 mRNA by inhibiting the phos-
phorylation of p38 MAPK. 
 The present investigation showed that ES 
products suppress cox-2 mRNA expression and 
cox-2 protein production, which may attenuate in-
ﬂammation around the plerocercoids.
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